益生元的胃肠道效应。

Gastrointestinal effects of prebiotics.

作者信息

Cummings J H, Macfarlane G T

机构信息

Department of Molecular and Cellular Pathology, University of Dundee, Ninewells Hospital and Medical School, UK.

出版信息

Br J Nutr. 2002 May;87 Suppl 2:S145-51. doi: 10.1079/BJNBJN/2002530.

Abstract

The defining effect of prebiotics is to stimulate selectively the growth of bifidobacteria and lactobacilli in the gut and, thereby, increase the body's natural resistance to invading pathogens. Prebiotic carbohydrates may also have additional, less specific, benefits because they are fermented in the large intestine. The prebiotic carbohydrates that have been evaluated in humans at the present time largely consist of fructans or galactans. There is consistent evidence from in vitro and in vivo studies that these are not digested by normal human enzymes, but are readily fermented by anaerobic bacteria in the large intestine. There are no reports of faecal recovery of measurable quantities of prebiotic carbohydrates. Through fermentation in the large intestine, prebiotic carbohydrates yield short-chain fatty acids, stimulate the growth of many bacterial species in addition to the selective effects on lactobacilli and bifidobacteria, they can also produce gas. Along with other fermented carbohydrates, prebiotics have mild laxative effects, although this has proved difficult to demonstrate in human studies because the magnitude of laxation is small. Potentially, the most important effect of prebiotic carbohydrates is to strengthen the body's resistance to invading pathogens and, thereby, prevent episodes of diarrhoea. At the present time, this effect has not been convincingly demonstrated in either adults or children, although there have been attempts to ameliorate the diarrhoea associated with antibiotics and travel, but without success. However, prebiotic carbohydrates clearly have significant and distinctive physiological effects in the human large intestine, and on the basis of this it is likely that they will ultimately be shown to be beneficial to health.

摘要

益生元的决定性作用是选择性地刺激肠道中双歧杆菌和乳酸菌的生长,从而增强人体对入侵病原体的天然抵抗力。益生元碳水化合物可能还有其他不那么特定的益处,因为它们在大肠中会被发酵。目前在人体中评估的益生元碳水化合物主要由果聚糖或半乳聚糖组成。体外和体内研究都有一致的证据表明,这些物质不会被人体正常酶消化,但很容易被大肠中的厌氧菌发酵。没有关于可测量数量的益生元碳水化合物在粪便中回收的报道。通过在大肠中发酵,益生元碳水化合物会产生短链脂肪酸,除了对乳酸菌和双歧杆菌有选择性作用外,还能刺激许多细菌种类的生长,它们也会产生气体。与其他发酵碳水化合物一样(一样),益生元有轻度的通便作用,尽管在人体研究中很难证明这一点,因为通便程度很小。益生元碳水化合物潜在的最重要作用是增强人体对入侵病原体的抵抗力,从而预防腹泻发作。目前,这一作用在成人和儿童中都尚未得到令人信服的证明,尽管有人试图改善与抗生素和旅行相关的腹泻,但没有成功。然而,益生元碳水化合物在人类大肠中显然具有显著且独特的生理作用,基于此,它们最终可能会被证明对健康有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索